HALOZYME THERAPEUTICS INC shareholders Q3 2023

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SRS Capital Advisors, Inc. 54$2,0640.00%
Citadel Advisors 36,100$1,379,0200.00%
Citadel Advisors 7,400$282,6800.00%
FARMERS & MERCHANTS INVESTMENTS INC 57$2,1770.00%
AdvisorNet Financial, Inc 19$7260.00%
Rosenberg Matthew Hamilton 1$380.00%
Baker Avenue Asset Management, LP 7$2670.00%
Allworth Financial LP 1,122$42,8610.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 34,100$1,302,6200.00%
BESSEMER GROUP INC 211$80.00%
Global Retirement Partners, LLC 59$2,1970.00%
FIRST TRUST ADVISORS LP 7,553$288,5240.00%
Amundi 14,600$533,6300.00%
NewEdge Advisors, LLC 213$8,1370.00%
Walleye Capital LLC 3,400$129,8800.00%
Walleye Capital LLC 4,800$183,3600.00%
MILLENNIUM MANAGEMENT LLC 7,400$282,6800.00%
Walleye Trading LLC 3,000$114,6000.00%
FMR LLC 126,818$4,844,4560.00%
Mitsubishi UFJ Asset Management Co., Ltd. 85$3,2470.00%
External links

This page lists HALOZYME THERAPEUTICS INC's shareholders in Q3 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.